Directed production of aurantizolicin and new members based on a YM-216391 biosynthetic system†
Abstract
Using a highly effective heterologous expression system, the YM-216391 (1) biosynthetic gene cluster was engineered to yield aurantizolicin (2) and the hybrid compound 3. Both of these compounds were isolated and fully structurally characterised and the bioactivity was evaluated. The results indicate that compound 3 exhibits significantly improved antitumor activity.
- This article is part of the themed collections: Chemical Biology in OBC and Biosynthesis